Reply: Call for Regular Susceptibility Testing of Bedaquiline and Delamanid
- 1 November 2016
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 194 (9) , 1171-1172
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2016
- Delamanid susceptibility testing ofMycobacterium tuberculosisusing the resazurin microtitre assay and the BACTEC™ MGIT™ 960 systemJournal of Antimicrobial Chemotherapy, 2016
- Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan RefugeeAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyThe Lancet Infectious Diseases, 2015
- Multidrug-resistant tuberculosis around the world: what progress has been made?European Respiratory Journal, 2014
- Acquired Resistance of Mycobacterium tuberculosis to BedaquilinePLOS ONE, 2014